Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep738 | Pituitary: clinical | ECE2015

Obstructive sleep apnoea is common in patients who have had surgery for non-functioning pituitary adenomas; preliminary data

Hernandez Martin Cuesta , Crowley Rachel , Costello Richard , Thompson Christopher

Introduction: Some patients complain of excessive daytime somnolence following pituitary surgery.Aim: To investigate the presence of obstructive sleep apnoea (OSA) following surgery for non functioning pituitary adenomas (NFPA).Design and methods: We assessed the prevalence of OSA in 16 routinely selected patients following surgery for NFPA and 13 obese controls attending a tertiary referral centre, by means of the Epworth Sleepine...

ea0037gp.17.07 | Pituitary–Neuroendocrinology and central salt regulation | ECE2015

Heterogenous patterns of recovery from adipsic diabetes insipidus in adult patients

Hernandez Martin Cuesta , Dineen Rosemary , Gupta Saket , Salehmohamed Ridhwaan , Thompson Christopher

Introduction: The natural history of adipsic diabetes insipidus (ADI) is not completely understood. Isolated case reports suggest occasional recovery of adipsia. We present the follow up of a cohort of 12 patients with ADI.Setting: National pituitary unit with interest in diabetes insipidus.Methods: ADI was identified by demonstrating absent thirst and AVP responses to hypertonic saline infusion. Results 12 patients with ADI were i...

ea0037ep703 | Pituitary: basic and neuroendocrinology | ECE2015

Mortality in SIADH is similar to that in non-SIADH hyponatraemia; preliminary data

Thompson Christopher J , Slattery David , Gupta Saket , Tormey William , Hernandez Martin Cuesta

Introduction: Excess mortality due to hyponatraemia is well documented but it is not clear whether the mortality associated with SIADH is different to that associated with non-SIADH hyponatraemia (NSH).Methods/design: Prospective evaluation of all patients admitted with or developing hyponatraemia in a tertiary hospital (pNa <130 mmol/l) in January 2015. Diagnosis of SIADH was based on standard clinical and biochemical criteria (pNa, spot urine sodiu...

ea0063p8 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Metabolic and cardiovascular profile of 143 adrenal incidentalomas

Araujo-Castro Marta , Nunez Miguel Sampedro , Ramirez Paola Parra , Lazaro Cristina Robles , Hernandez Martin Cuesta , Marazuela Monica

Objective: To study the differences in the metabolic profile of patients with non-functioning adrenal adenomas (NFA) and autonomous cortisol secretion (ACS).Methods: 143 patients diagnosed of adrenal incidentaloma (AI) between 2010 and 2018 were retrospectively analyzed. AI was defined as an adrenal mass≥1 cm, accidentally discovered by radiologic examination. ACS was confirmed by serum cortisol post-dexamethasone suppression test (Nugent)≥3 ...

ea0041ep597 | Endocrine tumours and neoplasia | ECE2016

Phaeochromocytomas and paragangliomas: A comparative study between sporadic and familial cases in a reference care center in Spain

Luis Guillermo Ropero , Perez Jose Angel Diaz , Gracia Teresa Ruiz , Hernandez Martin Cuesta , Hoyos Emilia Gomez , Hernandez Irene Crespo , Novoa Paz de Miguel

Introduction: Hereditary phaeochromocytoma (PCC) and paraganglioma (PGL) account for 30–35% of cases and have some clinically relevant peculiarities.Material and methods: Retrospective, unicentric cohort study that included all genotyped patients (n=36, 27 with PCC and 9 with PGL) diagnosed at Hospital Clínico San Carlos (Madrid) between 1984 and 2013; 33% were germline mutation carriers (25% pseudohypoxic [PH] phenotype, 75% MAP-kinas...

ea0041ep603 | Endocrine tumours and neoplasia | ECE2016

Medullary Thyroid Cancer: a comparative study between sporadic and familial cases in a reference care center in Spain

Luis Guillermo Ropero , Perez Jose Angel Diaz , Hoyos Emilia Gomez , Hernandez Martin Cuesta , Hernandez Irene Crespo , Gracia Teresa Ruiz , de Miguel Novoa Paz

Introduction: Hereditary Medullary Thyroid Cancer (MTC) accounts for 20–30% of cases and has some clinically relevant peculiarities.Material and methods: Retrospective, unicentric cohort study that included all genotyped patients with MTC (n=48) diagnosed at Hospital Clínico San Carlos (Madrid) between 1984–2013; 42% were germline mutation carriers (45% moderate risk (category MOD), 45% high risk (category H), 10% highest risk (ca...

ea0037ep744 | Pituitary: clinical | ECE2015

Symptoms of gonadal dysfunction are more predictive of hypopituitarism than non-specific symptoms in screening for pituitary dysfunction following moderate or severe traumatic brain injury

Hernandez Martin Cuesta , Hannon Mark J , Crowley Rachel K , Behan Lucy Ann , Tormey William , Rawluk Daniel , Delargy Mark , Agha Amar , Thompson Christopher J

Context: The economic and logistic burden of screening for hypopituitarism following moderate/severe traumatic brain injury (TBI) is considerable. Published guidelines suggest prioritisation for screening of patients with symptoms of pituitary dysfunction.Objective: To evaluate the implementation of targeted symptom-based screening for hypopituitarism after moderate/severe TBI, compared with routine consecutive screening.Design: Gr...

ea0032p54 | Adrenal cortex | ECE2013

Hyperaldosteronism in patients with hyperparathyroidism: three cases

Gracia Teresa Ruiz , Capel Francisco Fernandez , Zamorano Nuria Fuertes , Hoyos Emilia Gomez , Hernandez Martin Cuesta , Pascual Alfonso Calle , De La Vega Isabelle Runkle

Introduction: Hyperaldosteronism can induce elevated parathyroid hormone (PTH) levels, presumably by increasing calciuria. Furthermore, PTH stimulates aldosterone secretion in vitro, and increases angiotensin–II-stimulated aldosterone release. In a patient with hyperaldosteronism and hyperparathyroidism, PTH receptors were detected in aldosteronoma tissue. We present three patients sent to an endocrinologist for treatment/follow-up of primary hyperparathyroidism,...

ea0090ep720 | Pituitary and Neuroendocrinology | ECE2023

Increased mortality in COVID-19 patients with admission hyponatremia is associated with sustained hyponatremia, and volemia-inappropriate therapy

Guerra Mario Pazos , Sanchez Jorge Gabriel Ruiz , Candel Xavier Perez , Nevado Celia Lopez , Olmeda Fernando Hernandez , Monteros Patricia Espinosa De Los , Hernandez Martin Cuesta , Calle Alfonso , Martin Javier Sanchez , Runkle Isabel

Introduction: Admission hyponatremia, frequently detected in patients hospitalized for COVID-19, has been associated with increased mortality. However, although SIADH-induced euvolemic hyponatremia is the single most-common cause of hyponatremia in community-acquired pneumonia, repercussions of admission-hyponatremia volemic classification on COVID-19 hospitalizations have yet to be described. We sought to identify factors contributing to mortality and hospital length-of-stay ...

ea0049gp179 | Pituitary | ECE2017

Correction of sustained hyponatremia secondary to SIAD by the use of chronic tolvaptan therapy is associated with a reduction in Emergency Room visits, hospital admissions and days of hospitalization over a 3-year period

Hernandez Martin Cuesta , Hernandez Irene Crespo , Alemany Pablo Amich , Hoyos Emilia Gomez , Gomez Nancy Sanchez , Santiago Alejandro , De Miguel Novoa Paz , Calle-Pascual Alfonso Luis , de la Vega Isabelle Runkle

Introduction: Hyponatremia (HN) is associated with worse clinical outcomes, and longer hospital lengths-of-stay than seen in eunatremic patients. The Syndrome of Inappropriate Antidiuresis (SIAD) is the most common cause of hyponatremia in hospitalization. We studied the relationship between correction of sustained SIAD-induced hyponatremia and visits to the Emergency Room (ERv) as well as hospital admissions (HA) in a case series.Methods: Retrospective,...